| 中文名 | 4-氨基-4-(4-溴苯基)哌啶-1-羧酸叔丁酯 |
|---|---|
| 英文名 | tert-butyl 4-amino-4-(4-bromophenyl)piperidine-1-carboxylate |
| 英文别名 | 4-amino-4-(4-bromo-phenyl)piperidine-1-carboxylic acid tert-butyl ester |
| 分子式 | C16H23BrN2O2 |
|---|---|
| 分子量 | 355.27000 |
| 精确质量 | 354.09400 |
| PSA | 55.56000 |
| LogP | 4.27220 |
| 储存条件 | 2-8°C,避光,干燥,密封 |
| 危害码 (欧洲) | Xi |
|---|---|
| 海关编码 | 2933399090 |
|
~96%
917925-62-3 |
| 文献:ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL; ASTRAZENECA AB Patent: WO2006/136829 A2, 2006 ; Location in patent: Page/Page column 127-128 ; WO 2006/136829 A2 |
| 海关编码 | 2933399090 |
|---|---|
| 中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |